Remdesivir inhibits the coronavirus RNA dependent RNA polymerase RdRp #200413822
Description
The nucleotide analog remdesivir blocks the SARS-CoV-2 RNA dependent RNA polymerase and is a promising drug for the treatment of COVID-19. RdRp is an enzyme that catalyzes the replication of RNA from an RNA template.. PDB entry 6yy7